rss
J Clin Pathol doi:10.1136/jcp.2008.057158

LARGE VOLUME "MAMMOTOME" BIOPSY MAY REDUCE THE NEED FOR DIAGNOSTIC SURGERY IN PAPILLARY LESIONS OF THE BREAST

  1. Pauline J Carder (paulinecarder{at}doctors.org.uk)
  1. Bradford Teaching Hospitals NHS Foundation Trust, United Kingdom
    1. Tahir Khan (tahir.khan{at}bradfordhospitals.nhs.uk)
    1. Bradford Teaching Hospitals NHS Foundation Trust, United Kingdom
      1. Paul Burrows (paul.burrows{at}bradfordhospitals.nhs.uk)
      1. Bradford Teaching Hospitals NHS Foundation Trust, United Kingdom
        1. Nisha Sharma (nisha.sharma{at}bradfordhospitals.nhs.uk)
        1. Bradford Teaching Hospitals NHS Foundation Trust, United Kingdom
          • Published Online First 21 May 2008

          Abstract

          Background: There is currently debate as to whether all papillary lesions diagnosed on breast needle core biopsy require surgical excision. The recent development of large volume “mammotome” biopsy offers a means of non-operative removal. There is little published data regarding the success of this approach.

          Aim: To review the pathological and radiological findings in cases of non-diagnostic “B3” and “B4” papillary lesions identified on conventional breast needle core biopsy with a view to assessing the usefulness of mammotome biopsy as a means of avoiding diagnostic surgery.

          Methods: All breast core biopsies containing a “B3” or “B4” papillary lesion between 23/06/05 and 14/08/07 were identified by searching the pathology department computer records. Follow up histology was identified from pathology department computer records and radiological details were obtained from the local screening unit or the radiology department.

          Results: Thirty-four papillary breast core biopsies were included in this study. Twenty-one were from screen-detected lesions and thirteen were from patients presenting symptomatically. Thirty-one were classified “B3” and three were “B4s”. Four cases included an atypical ductal epithelial proliferation (all “B4”s and one “B3”).Fourteen patients underwent open surgical biopsy, fifteen mammotome excision and five had no subsequent procedure. All fifteen cases who underwent mammotome biopsy did not show atypia on the core and thirteen (87%) proved benign. In two cases the mammotome biopsy was either atypical or malignant prompting surgery at this point. In both cases the mammotome biopsy changes derived from areas of ductal carcinoma in situ (DCIS) arising in the context of multiple intraduct papillomas and both were distinctive mammographically in presenting with large areas of segmental calcification. Eleven of the fourteen cases undergoing surgical excision did not show atypia on the core and all proved benign. All three with atypia on the core proved malignant.

          Conclusion: In selected cases, large volume (“mammotome”) biopsy may improve sampling of papillary lesions such that malignancy may be excluded without recourse to diagnostic surgery. The presence of an atypical papillary proliferation on core or mammotome biopsy is a strong predictor of malignancy. This has important implications for both symptomatic and breast screening services.

          Latest from JCP Education

          Latest from JCP Education

          Register for free content


          Free sample
          This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
          View free sample issue >>

          Free archive
          The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
          Register to access the free archive >>

          Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

        1. Latest Pathology jobs

          Latest Pathology jobs